Campbell & CO Investment Adviser LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$533,317
-63.3%
6,264
-64.3%
0.10%
-64.9%
Q1 2023$1,453,918
+28.8%
17,570
+22.5%
0.27%
+0.4%
Q4 2022$1,128,392
+432.3%
14,347
+341.9%
0.27%
+373.7%
Q2 2022$212,000
-23.2%
3,247
+35.1%
0.06%
-32.9%
Q4 2019$276,000
-18.1%
2,403
-9.9%
0.08%
-33.1%
Q3 2019$337,0002,6680.13%
Other shareholders
HAEMONETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders